Vaccinia virus vectors related to MVA with extensive genomic symmetries
AssigneeProbiogen AG
InventorsIngo Jordan, Volker Sandig
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel Modified Vaccinia Ankara (MVA) related virus. The present invention also relates to a method for culturing said MVA related virus and to a method for producing said MVA related virus. Further, the present invention relates to a pharmaceutical composition comprising said MVA related virus and one or more pharmaceutical acceptable excipient(s), diluent(s), and/or carrier(s). Furthermore, the present invention relates to a vaccine comprising said MVA related virus. In addition, the present invention relates to said MVA related virus for use in medicine.
Claims15
A Modified Vaccinia Ankara (MVA) related virus comprising one or more of the following features:
- (i) a nucleic acid sequence corresponding to a region that includes the right Inverted Terminal Repeat (ITR) and extends to but excludes deletion site III instead of a nucleic acid sequence that includes the left Inverted Terminal Repeat (ITR) and extends to but excludes deletion site V, wherein the region that includes the right ITR and extends to but excludes deletion site III has a nucleic acid sequence according to SEQ ID NO:
- 37 or Genbank Accession number KY633487 or is a variant thereof which is at least 95% identical to said nucleic acid sequence, and/or wherein the region that includes the left ITR and extends to but excludes deletion site V has a nucleic acid sequence according to SEQ ID NO:
- 37 or Genbank Accession number KY633487 or is a variant thereof which is at least 95% identical to said nucleic acid sequence,
- and
- (ii) two copies of a nucleic acid sequence comprising deletion site IV and the right ITR, wherein the nucleic acid sequence comprising deletion site IV and the right ITR has a nucleic acid sequence according to SEQ ID NO:
- 37 or Genbank Accession number KY633487 or is a variant thereof which is at least 95% identical to said nucleic acid sequence.
Dependencies are inferred from the claim text.